“Inhibitory Peptides Identified as Potential Therapeutic Lead for Suppressing Toxic Fibril Formation in Mutant Huntingtin Proteins Related to Huntington’s Disease”

https://pubmed.ncbi.nlm.nih.gov/38116434

Researchers have identified inhibitory peptides that suppress the formation of toxic fibrils in mutant Huntingtin proteins associated with Huntington’s disease, providing a potential therapeutic lead for further optimization and development.